Kuiperij HB - Search Results

1

A Practical Guide to Immunoassay Method Validation.

Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, Fladby T, Genc S, Kruse N, Kuiperij HB, Kulic L, Lewczuk P, Mollenhauer B, Mroczko B, Parnetti L, Vanmechelen E, Verbeek MM, Winblad B, Zetterberg H, Koel-Simmelink M, Teunissen CE. Andreasson U, et al. Among authors: kuiperij hb. Front Neurol. 2015 Aug 19;6:179. doi: 10.3389/fneur.2015.00179. eCollection 2015. Front Neurol. 2015. PMID: 26347708 Free PMC article.

2

Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?

Timmer NM, Kuiperij HB, de Waal RM, Verbeek MM. Timmer NM, et al. Among authors: kuiperij hb. J Alzheimers Dis. 2010;22(2):345-55. doi: 10.3233/JAD-2010-100711. J Alzheimers Dis. 2010. PMID: 20847441 Review.

3

Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?

Kuiperij HB, Verbeek MM. Kuiperij HB, et al. Neurobiol Aging. 2012 Jan;33(1):204.e17-8. doi: 10.1016/j.neurobiolaging.2010.08.011. Epub 2010 Oct 13. Neurobiol Aging. 2012. PMID: 20947213

4

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.

Kuiperij HB, Verbeek MM. Kuiperij HB, et al. Neurology. 2011 Apr 19;76(16):1443; author reply 1443. doi: 10.1212/WNL.0b013e318210e671. Neurology. 2011. PMID: 21502610 No abstract available.

5

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

Bruggink KA, Kuiperij HB, Ekholm-Pettersson F, Verbeek MM. Bruggink KA, et al. Among authors: kuiperij hb. Neurology. 2011 Aug 2;77(5):510; author reply 510-1. doi: 10.1212/WNL.0b013e318219dd92. Neurology. 2011. PMID: 21810701 No abstract available.

6

Inhibition of α-synuclein aggregation by small heat shock proteins.

Bruinsma IB, Bruggink KA, Kinast K, Versleijen AA, Segers-Nolten IM, Subramaniam V, Kuiperij HB, Boelens W, de Waal RM, Verbeek MM. Bruinsma IB, et al. Among authors: kuiperij hb. Proteins. 2011 Oct;79(10):2956-67. doi: 10.1002/prot.23152. Epub 2011 Aug 26. Proteins. 2011. PMID: 21905118

7

Methods for analysis of amyloid-β aggregates.

Bruggink KA, Müller M, Kuiperij HB, Verbeek MM. Bruggink KA, et al. Among authors: kuiperij hb. J Alzheimers Dis. 2012;28(4):735-58. doi: 10.3233/JAD-2011-111421. J Alzheimers Dis. 2012. PMID: 22156047 Review.

8

Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol.

Herbert MK, Kuiperij HB, Verbeek MM. Herbert MK, et al. Among authors: kuiperij hb. J Immunol Methods. 2012 Jul 31;381(1-2):1-8. doi: 10.1016/j.jim.2012.04.001. Epub 2012 Apr 19. J Immunol Methods. 2012. PMID: 22542401

9

TDP-43 plasma levels are higher in amyotrophic lateral sclerosis.

Verstraete E, Kuiperij HB, van Blitterswijk MM, Veldink JH, Schelhaas HJ, van den Berg LH, Verbeek MM. Verstraete E, et al. Among authors: kuiperij hb. Amyotroph Lateral Scler. 2012 Sep;13(5):446-51. doi: 10.3109/17482968.2012.703208. Epub 2012 Aug 8. Amyotroph Lateral Scler. 2012. PMID: 22873561

10

Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue.

Bruggink KA, Jongbloed W, Biemans EA, Veerhuis R, Claassen JA, Kuiperij HB, Verbeek MM. Bruggink KA, et al. Among authors: kuiperij hb. Anal Biochem. 2013 Feb 15;433(2):112-20. doi: 10.1016/j.ab.2012.09.014. Epub 2012 Sep 26. Anal Biochem. 2013. PMID: 23022042 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters